304
Views
5
CrossRef citations to date
0
Altmetric
Original Paper

Role of silymarin (Silybum marianum) in the prevention of colistin-induced acute nephrotoxicity in rats

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 568-575 | Received 15 Nov 2019, Accepted 10 Feb 2020, Published online: 16 Mar 2020

References

  • Arslan, B.Y., et al., 2016. Luteolin ameliorates colistin-induced nephrotoxicity in the rat models. Renal Failure, 38 (10), 1735–1740.
  • Desplaces, A., et al., 1975. The effects of silymarin on experimental phalloidine poisoning. Arzneimittelforschung, 25 (1), 89–96.
  • Dabak, D.O., and Kocaman, N., 2015. Effects of silymarin on methotrexate-induced nephrotoxicity in rats. Renal Failure, 37 (4), 734–739.
  • Falagas, M.E., Kasiakou, S.K., and Saravolatz, L.D., 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clinical Infectious Diseases, 40 (9), 1333–1341.
  • Ferenci, P., et al., 1989. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. Journal of Hepatology, 9 (1), 105–113.
  • Gai, Z., et al., 2019. Molecular mechanisms of colistin-induced nephrotoxicity. Molecules, 24 (3), 653.
  • Ghaznavi, H., et al., 2016. Comparison of the protective effects of melatonin and silymarin against gentamicin-induced nephrotoxicity in rats. Journal of Evidence-Based Complementary & Alternative Medicine, 21 (4), NP49–NP55.
  • Ghlissi, Z., et al., 2013. Evaluation of colistin nephrotoxicity administered at different doses in the rat model. Renal Failure, 35 (8), 1130–1135.
  • Guzel, S., et al., 2019. Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats. Drug and Chemical Toxicology, 12, 1–7.
  • Halim, A.B., et al., 1997. Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage. Annals of Clinical Biochemistry, 34 (6), 656–663.
  • Hassan, S.S., et al., 2017. Possible protective role of silybin against polymyxin E-induced toxic effect in rat kidneys: a biochemicalapproach. Neurourology and Urodynamics, 36 (8), 2003–2010.
  • Hassan, S.S., et al., 2017. Does silybin protect against toxicity induced by polymyxin E in rat kidney? Neurourology and Urodynamics, 36 (5), 1278–1287.
  • Hruby, K., et al., 1983. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Human Toxicology, 2 (2), 183–195.
  • Hunter, M.I.S., Nlemadim, B.C., and Davidson, D.L.W., 1985. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluids from multiple sclerosis patients. Neurochemical Research, 10 (12), 1645–1652.
  • Lee, S-h., et al., 2015. P-Glycoprotein Induction ameliorates colistin induced nephrotoxicity in cultured human proximal tubular cells. PLoS One, 10 (8), e0136075.
  • Lee, T.W., et al., 2019. The aqueous extract of aged black garlic ameliorates colistin-induced acute kidney injury in rats. Renal Failure, 41 (1), 24–33.
  • Li, J., et al., 2005. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. International Journal of Antimicrobial Agents, 25 (1), 11–25.
  • Li, J., et al., 2006. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infectious Diseases, 6 (9), 589–601.
  • Miguez, M.P., et al., 1994. Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1. Chemico-Biological Interactions, 91 (1), 51–63.
  • Morazzoni, P., Montalbetti, A., Malandrino, S., and Pifferi, G., 1993. Comparative pharmacokinetics of silipide and silymarin in rats. European Journal of Drug Metabolism and Pharmacokinetics, 18 (3), 289–297.
  • Oliota, A.F., et al., 2019. Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies. Diagnostic Microbiology and Infectious Disease, 94 (1), 41–49.
  • Ozkan, G., et al., 2013. How does colistin-induced nephropathy developand can it be treated? Antimicrobial Agents and Chemotherapy, 57 (8), 3463–3469.
  • Ozyilmaz, E., et al., 2011. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Medicine, 37 (1), 141–146.
  • Salmi, H.A., and Sarna, S., 1982. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scandinavian Journal of Gastroenterology, 17 (4), 517–521.
  • Samodelov, S.L., et al., 2019. Renal glycosuria as a novel early sign of colistin-induced kidney damage in mice. Antimicrobial Agents and Chemotherapy, 63 (12), AAC.01650-19.
  • Shahbazi, F., et al., 2015. Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double-blinded, placebo-controlled clinical trial. Phytotherapy Research, 29 (7), 1046–1053.
  • Sonnenbichler, J., et al., 1986. Stimulatory effect of Silibinin on the DNA synthesis in partially hepatectomized rat livers: non-response in hepatoma and other maligncelllines. Biochemical Pharmacology, 35 (3), 538–541.
  • Soodvilai, S., et al., 2018. Effects of silymarin-loaded amphiphilic chitosan polymeric micelles on the renal toxicity and anticancer activity of cisplatin. Pharmaceutical Development and Technology, 24 (8), 927–934.
  • Talih, G., et al., 2018. Does dexmedetomidine prevent colistin nephrotoxicity? Brazilian Journal of Anesthesiology (English Edition), 68 (4), 383–387.
  • Tan, J., et al., 2015. Protective role of silymarin in a mouse model of renal Ischemia-Reperfusion injury. Diagnostic Pathology, 10 (1), 198.
  • Vaid, M., and Katiyar, S.K., 2010. Molecular mechanisms of inhibition of photo carcinogenesis by silymarin, a phyto chemical from milk thistle (Silybum marianum L. Gaertn.) (Review). International Journal of Oncology, 36, 1053–1060.
  • Vogel, G., et al., 1984. Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicology and Applied Pharmacology, 73 (3), 355–362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.